Table 2.
Laboratory characteristics of African American–DHS study participants (mean (s.d.) median)
| Female (n = 270) | Male (n = 152) | All (n = 422) | |
|---|---|---|---|
| GFR, ml/s | 1.38 (0.5) 1.31 | 1.46 (0.5) 1.39 | 1.41 (0.5) 1.35 |
| Urine albumin: creatinine, mg/g | 241.8 (828) 16.3 | 209.6 (618.4) 19 | 230.1 (758.4) 17.5 |
| Serum creatinine, μmol/l | 85.8 (35.4) 79.6 | 106.1 (35.4) 97.2 | 92.8 (35.4) 88.4 |
| Fasting blood sugar, mmol/l | 8.6 (3.7) 7.8 | 8.9 (4.3) 8.0 | 8.7 (3.9) 7.9 |
| HbA1c, proportion of total | 0.085 (0.03) 0.078 | 0.084 (0.02) 0.080 | 0.085 (0.02) 0.079 |
| Serum calcium, mmol/l | 2.38 (0.1) 2.38 | 2.35 (0.1) 2.35 | 2.35 (0.1) 2.38 |
| Serum phosphorus, mmol/l | 1.13 (0.2) 1.13 | 1.07 (0.2) 1.03 | 1.10 (0.2) 1.10 |
| 25-hydroxyvitamin D, nmol/l | 49.5 (30.4) 39.9 | 44.4 (21.6) 42.4 | 47.5 (27.2) 41.2 |
| Coronary CP | 548 (1452) 23 | 882 (1824) 111 | 669 (1602) 52 |
| Coronary CP >0% | 215 (80.83) | 125 (83.33) | 340 (81.73) |
| Carotid CP | 164 (531) 2 | 194 (651) 6 | 175 (576) 3 |
| Carotid CP >0% | 143 (54.17) | 88 (58.67) | 231 (55.80) |
| Aorta CP | 4697 (8991) 651 | 5192 (11225) 1014 | 4883 (9879) 724 |
| Aorta CP >0% | 198 (82.85) | 120 (88.33) | 318 (83.03) |
| HDL-cholesterol, mmol/l | 1.31 (0.4) 1.30 | 1.15 (0.3) 1.14 | 1.25 (0.4) 1.19 |
| LDL cholesterol, mmol/l | 2.91 (1.0) 2.85 | 2.78 (1.0) 2.67 | 2.87 (1.0) 2.77 |
| Triglycerides, mmol/l | 1.39 (1.3) 1.08 | 1.53 (2.0) 1.18 | 1.45 (1.6) 1.13 |
| PAT, cm3/45 mm | 82.4 (31.3) 77.3 | 90.3 (43) 79.8 | 85.3 (36.1) 78.7 |
| Visceral adipose tissue, cm3/15 mm | 174.4 (63.8) 167.8 | 175.9 (79.9) 166.2 | 174.9 (70.1) 167.8 |
| Intermuscular adipose tissue, cm3/15 mm | 11.9 (7.5) 10.3 | 9.6 (7.2) 7.8 | 11.1 (7.4) 9.3 |
| Subcutaneous adipose tissue, cm3/15 mm | 498.9 (172.8) 485.7 | 332.4 (154.9) 313.4 | 437.1 (184.7) 415.2 |
CP, calcified atherosclerotic plaque; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PAT, pericardial adipose tissue.